HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Crown To Acquire StriVectin, Appoint Its President Chief Commercial Officer

Executive Summary

StriVectin president Cori Aleardi will join Crown’s executive leadership team, helping to merge the businesses and drive growth across Crown’s brand portfolio, which includes PanOxyl acne wash, Blue Lizard Australian Sunscreen, the SkinPen microneedling device, and prescription skin creams.

You may also be interested in...



Soapbox, YENSA, Vegamour Among Fastest-Growing Cosmetics Companies On Inc. 5000

Inc. 5000 ranks the fastest-growing privately held companies in the US. With three-year growth of nearly 2,200%, Soapbox came in at No. 198 on the 2021 list, outpacing other beauty and personal-care companies that had enviable showings nevertheless in a year of unprecedented challenges.

Crown Grows With Keri From GSK, Which Says Little On Consumer Pending JV Launch With Pfizer

Sales to Crown Labs didn't breach GSK's attention when it reported its Q1 results, with its consumer health discussion limited to general figures on regions and product categories. Pfizer offered even less about its consumer health operations and plans with its Q1 report.For Crown Labs, landing North American rights to Keri brand marks another step toward offering comprehensive skin care selection.

Catterton Tries Its Luck On "Stretch-Mark Cream Turned Anti-Wrinkle Phenom"

Private equity firm Catterton Partners augments its cosmeceutical portfolio with the acquisition of an early trailblazer across the cosmetics/pharmaceuticals frontier, StriVectin

Topics

UsernamePublicRestriction

Register

RS151715

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel